Heart Failure in Ethiopian Children: Mirroring the Unmet Cardiac Services

Bezaye Nigussie1, Henok Tadele1

  • 1College of Medicine and Health Sciences, Hawassa University, Hawassa, Ethiopia.

Insights

Pediatric heart failure (HF) in Ethiopia is primarily caused by structural heart disease, with rheumatic and congenital conditions being most common. This study highlights HF

Area of Science:

  • Pediatric Cardiology
  • Global Health
  • Clinical Epidemiology

Background:

  • Heart failure (HF) is a significant clinical syndrome with limited research in Sub-Saharan Africa, particularly Ethiopia.
  • Understanding the patterns and outcomes of pediatric HF is crucial for improving healthcare in the region.

Purpose of the Study:

  • To describe the pattern and outcomes of pediatric heart failure (HF) at a referral-teaching hospital in Ethiopia.
  • To identify the common causes and precipitating factors of HF in children.

Main Methods:

  • A retrospective review of medical records for 216 children diagnosed with HF between January 2014 and January 2016.
  • Data analysis included descriptive statistics presented in tables and pie charts.

Main Results:

  • Heart failure (HF) constituted 10.8% of pediatric admissions, with structural heart disease (rheumatic and congenital) as the leading cause.
  • Congenital heart disease (CHD) was more prevalent in children under 5 years, while rheumatic heart disease (RHD) affected older children.
  • The case fatality rate for pediatric HF was 13.9%, with pneumonia and infective endocarditis as common comorbidities.

Conclusions:

  • Structural heart disease is the primary driver of pediatric heart failure (HF) in this Ethiopian setting.
  • Targeted echocardiographic screening and optimized management for structural heart disease are recommended.
  • Addressing HF in children requires a focus on underlying etiologies like CHD and RHD.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
894
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.5K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
865
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
329
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
963
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
305